NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID

Clinical trials for NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Radioactive drug tested to stop Cancer's return after liver surgery

Disease control Terminated

This study tested whether giving Lutathera, a targeted radioactive drug, after surgery to remove neuroendocrine tumor spread in the liver could prevent the cancer from coming back. It compared this treatment against standard monitoring and supportive care in patients whose primar…

Matched conditions: NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID

Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID

Get alerted when new NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID trials appear

Radioactive drug tested to stop Cancer's return after liver surgery